ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere, confirmed that while unsustainable workload increases have created an irrefutable urgency ...
AstraZeneca India and Indian Academy of Paediatrics Unite to raise awareness on respiratory syncytial virus in India: Our Bureau, Bengaluru Thursday, November 14, 2024, 16:45 Hrs ...
Biocon Academy achieves 100% placement for its 6th batch and concludes 5th edition of MCADDI residential programme for industry: Our Bureau, Bengaluru Thursday, November 14, 2024, ...
Caliway’s drug molecule CBL-514 to treat Dercum’s disease receives EMA orphan drug designation: New Taipei City Thursday, November 14, 2024, 16:00 Hrs [IST] Caliway Biopharmac ...
IDF research reveals diabetes impacts the mental well-being of over 4 in 5 Indians living with the condition: Our Bureau, Bengaluru Thursday, November 14, 2024, 15:45 Hrs [IST] In ...
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers: London, UK Thursday, November 14, 2024, 15:00 Hrs [IST] GSK plc announced t ...
The Union Ministry of Ayush (MoA) is working closely with the World Health Organization (WHO) to develop an International Herbal Pharmacopoeia (IHP) to set global quality and efficacy standards for ...
Researchers uncover new role of mutant proteins in some of the deadliest cancers: Maryland Thursday, November 14, 2024, 13:00 Hrs [IST] Researchers at the National Institutes of H ...
As part of its commitment to the global initiative to build stronger primary health care and health systems resilience, the Islamic Development Bank (IsDB) announced an important grant allocation of ...
Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...
Qiagen collaborates with McGill University to advance microbiome research: Montreal, Canada Thursday, November 14, 2024, 10:00 Hrs [IST] Qiagen, a Netherlands-based leading global ...
GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk primary ...